Metropolitan Life Insurance CO Mannkind Corp Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

52 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$3.25 - $5.27 $1,456 - $2,360	-448 Reduced 3.02%	14,382 $65,000
Q3 2023 Nov 14, 2023	BUY	$3.91 - $5.45 $3,315 - $4,621	848 Added 6.06%	14,830 $61,000
Q2 2023 Aug 10, 2023	BUY	$3.72 - $4.79 $4,914 - $6,327	1,321 Added 10.43%	13,982 $56,000
Q1 2023 May 15, 2023	SELL	$3.95 - $5.63 $9,258 - $13,196	-2,344 Reduced 15.62%	12,661 $51,000
Q4 2022 Jun 14, 2023	BUY	$3.02 - $5.37 $7,078 - $12,587	2,344 Added 18.51%	15,005 $79.1 Million
Q3 2022 Jun 14, 2023	BUY	$2.99 - $4.35 $7,008 - $10,196	2,344 Added 18.51%	15,005 $46.4 Million
Q3 2022 Mar 30, 2023	BUY	$2.99 - $4.35 $5,178 - $7,534	1,732 Added 13.05%	15,005 $46,000
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $5,178 - $7,534	1,732 Added 13.05%	15,005 $46,000
Q2 2022 Jun 20, 2023	BUY	$2.67 - $4.77 $1,634 - $2,919	612 Added 4.83%	13,273 $50,000
Q2 2022 Mar 30, 2023	SELL	$2.67 - $4.77 $7,411 - $13,241	-2,776 Reduced 17.3%	13,273 $50,000
Q2 2022 Aug 11, 2022	SELL	$2.67 - $4.77 $7,411 - $13,241	-2,776 Reduced 17.3%	13,273 $51,000
Q1 2022 Jun 20, 2023	BUY	$2.62 - $4.45 $8,876 - $15,076	3,388 Added 26.76%	16,049 $59,000
Q1 2022 Mar 30, 2023	SELL	$2.62 - $4.45 $102,447 - $174,003	-39,102 Reduced 70.9%	16,049 $59,000
Q1 2022 May 12, 2022	SELL	$2.62 - $4.45 $102,447 - $174,003	-39,102 Reduced 70.9%	16,049 $59,000
Q4 2021 Jun 21, 2023	BUY	$4.05 - $5.37 $172,084 - $228,171	42,490 Added 335.6%	55,151 $241,000
Q4 2021 Mar 30, 2023	SELL	$4.05 - $5.37 $9,067 - $12,023	-2,239 Reduced 3.9%	55,151 $241,000
Q4 2021 Feb 15, 2022	SELL	$4.05 - $5.37 $9,067 - $12,023	-2,239 Reduced 3.9%	55,151 $241,000
Q3 2021 Jun 21, 2023	BUY	$3.89 - $5.48 $173,995 - $245,114	44,729 Added 353.28%	57,390 $249,000
Q3 2021 Mar 30, 2023	SELL	$3.89 - $5.48 $30,766 - $43,341	-7,909 Reduced 12.11%	57,390 $249,000
Q3 2021 Nov 15, 2021	SELL	$3.89 - $5.48 $30,766 - $43,341	-7,909 Reduced 12.11%	57,390 $250,000
Q2 2021 Jun 21, 2023	BUY	$3.61 - $5.45 $190,023 - $286,877	52,638 Added 415.75%	65,299 $355,000
Q2 2021 Mar 30, 2023	BUY	$3.61 - $5.45 $72,781 - $109,877	20,161 Added 44.67%	65,299 $355,000
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $235,566 - $355,634	65,254 Added 145008.89%	65,299 $356,000
Q1 2021 Jun 26, 2023	BUY	$3.14 - $6.14 $101,977 - $199,408	32,477 Added 256.51%	45,138 $177 Million
Q1 2021 Mar 30, 2023	SELL	$3.14 - $6.14 $55,719 - $108,954	-17,745 Reduced 28.22%	45,138 $176,000
Q1 2021 May 14, 2021	SELL	$3.14 - $6.14 $197,311 - $385,825	-62,838 Reduced 99.93%	45 $177,000
Q4 2020 Jun 22, 2023	BUY	$1.79 - $4.04 $89,897 - $202,896	50,222 Added 396.67%	62,883 $196,000
Q4 2020 Mar 30, 2023	SELL	$1.79 - $4.04 $1,462 - $3,300	-817 Reduced 1.28%	62,883 $196,000
Q4 2020 Feb 16, 2021	SELL	$1.79 - $4.04 $1,462 - $3,300	-817 Reduced 1.28%	62,883 $197,000
Q3 2020 Jun 26, 2023	BUY	$1.56 - $2.08 $79,620 - $106,161	51,039 Added 403.12%	63,700 $119,000
Q3 2020 Mar 30, 2023	SELL	$1.56 - $2.08 $2,659 - $3,546	-1,705 Reduced 2.61%	63,700 $119,000
Q3 2020 Nov 13, 2020	SELL	$1.56 - $2.08 $2,659 - $3,546	-1,705 Reduced 2.61%	63,700 $120,000
Q2 2020 Jun 26, 2023	BUY	$0.94 - $2.21 $49,579 - $116,564	52,744 Added 416.59%	65,405 $114,000
Q2 2020 Mar 30, 2023	BUY	$0.94 - $2.21 $27,264 - $64,101	29,005 Added 79.68%	65,405 $114,000
Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $27,264 - $64,101	29,005 Added 79.68%	65,405 $114,000
Q1 2020 Jul 12, 2023	BUY	$0.84 - $1.76 $19,940 - $41,780	23,739 Added 187.5%	36,400 $37,000
Q1 2020 Mar 30, 2023	BUY	$0.84 - $1.76 $5,549 - $11,628	6,607 Added 22.18%	36,400 $37,000
Q1 2020 May 15, 2020	BUY	$0.84 - $1.76 $5,549 - $11,628	6,607 Added 22.18%	36,400 $37,000
Q4 2019 Jul 12, 2023	BUY	$1.14 - $1.49 $19,530 - $25,526	17,132 Added 135.31%	29,793 $38,000
Q4 2019 Mar 30, 2023	SELL	$1.14 - $1.49 $48,063 - $62,819	-42,161 Reduced 58.59%	29,793 $38,000
Q4 2019 Feb 14, 2020	SELL	$1.14 - $1.49 $48,063 - $62,819	-42,161 Reduced 58.59%	29,793 $38,000
Q3 2019 Jul 12, 2023	BUY	$1.04 - $1.44 $61,664 - $85,381	59,293 Added 468.31%	71,954 $89,000
Q3 2019 Mar 30, 2023	BUY	$1.04 - $1.44 $12,795 - $17,716	12,303 Added 20.62%	71,954 $89,000
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.44 $74,832 - $103,613	71,954 New	71,954 $90,000
Q2 2019 Jul 12, 2023	BUY	$1.09 - $1.88 $51,219 - $88,341	46,990 Added 371.14%	59,651 $68.6 Million
Q2 2019 Aug 14, 2019	SELL	$1.09 - $1.88 $65,019 - $112,143	-59,651 Closed	0 $0
Q1 2019 Jul 13, 2023	BUY	$1.14 - $2.25 $53,568 - $105,727	46,990 Added 371.14%	59,651 $117,000
Q1 2019 Mar 30, 2023	BUY	$1.14 - $2.25 $50,896 - $100,453	44,646 Added 297.54%	59,651 $117,000
Q1 2019 May 16, 2019	BUY	$1.14 - $2.25 $60,321 - $119,056	52,914 Added 785.42%	59,651 $117,000
Q1 2019 May 15, 2019	BUY	$1.14 - $2.25 $7,680 - $15,158	6,737 New	6,737 $784,000
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $52,973 - $114,863	-52,449 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$1.59 - $2.38 $83,393 - $124,828	52,449 New	52,449 $0

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account